Market Research Reports

Home Press Releases Biological Drugs Market is expected to reach USD 287,139.7 million in 2020

Biological Drugs Market is expected to reach USD 287,139.7 million in 2020



 
Posted on Jul 1, 2014
According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 287,139.7 million in 2020.

The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.

On the other hand, high cost of biological drugs and patent expiry of blockbuster drugs impede the growth of the market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020.

North America is the largest market for biological drugs. Increased use of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. The American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S.   

Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases. 

In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities.

Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are the some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc.

Browse the full Biological Drugs Market report at http://www.transparencymarketresearch.com/biological-drugs-market.html

The global market of biological drugs is segmented as follows:

Biological Drugs Market, By Therapeutic Protein
  • Enbrel
  • Lantus
  • Neulasta
  • Avonex
  • NovoLog
  • Rebif
  • Humalog
  • Aranesp
  • Epogen
  • Levemir
  • Victoza
  • Betaseron
  • Neupogen
  • Eylea
Biological Drugs Market, By Monoclonal Antibody (mAb)
  • Humira
  • Remicade
  • Rituxan
  • Avastin
  • Herceptin
  • Lucentis
Biological Drugs Market, By Vaccine
  • Prenvar 13
  • Gardasil
  • Fluzone
  • Varivax
  • Cervarix
Biological Drugs Market, by Geography
  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)
About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms. Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/
 

Share This Article!  


Related Report

  • Urinary Tract Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
  • Cancer associated with urinary tract is referred as urinary tract cancer. Cancer growth of cell arising from epithelial lining of urinary bladder results in urinary tract cancer. Elderly population is at a higher risk of urinary tract cancer. Although majority cases of urinary tract cancer are diagnosed at early stage, risk of re-occurrence of early diagnosed cancer is higher. Therefore, urinary tract cancer patients are recommended to undergo follow up tests...
  • Poisoning Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
  • Incidences of poisoning are fatal for most of the times and such incidences have risen over the years. WHO estimated that in 2004 approximately 346,000 people died globally due to unintentional poisoning. Moreover, more than a million people die annually due to suicide and deliberate ingestion of chemicals account for large number of these deaths. The increasing knowledge regarding the pharmacokinetics, pathology along with advancements in medicine has led to...
  • CNS Lymphoma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
  • Central Nervous System (CNS) lymphoma is also known as primary CNS lymphoma and microglioma, is a type of intracranial tumor observed in patients diagnosed with severe immunosupression (typically patients with AIDS). Primary CNS lymphoma initiates in the spinal cord, brain or meninges. While, most of primary CNS lymphomas are B-cell lymphomas and T-cell lymphomas are rare. The sign and symptoms of primary CNS lymphoma are diplopia, dysphagia, vertigo,...
Payment
Copyright @ Transparency Market Research